Paper
Mohammad A.I. Al-Hatamleh·+4 more
3/1/2026
CAR-T cell therapy researchHealth SciencesMedicineOncology
Chimeric antigen receptor (CAR) T cell therapy has achieved remarkable success in hematologic malignancies but faces significant challenges in solid tumors such as breast cancer. A primary obstacle is the immunosuppressive tumor microenvironment (TME), which drives T-cell exhaustion and limits therapeutic efficacy. Lymphocyte-activation gene 3 (LAG-3) is a key mediator of this exhaustion, suppres…
Based on the symptoms identified, finding treatments for post-COVID-19 syndrome is needed particularly for military personnel to maintain fitness and readiness.
research.ioCreate your feed subscriptions, save articles, keep scrolling.